A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)
Clinical trial NCT03150719 · COMPLETED
Trial details
- NCT number
- NCT03150719
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2018-08-09
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.